<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:j.0="http://purl.bioontology.org/ontology/RXNORM/31565"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:j.1="http://purl.bioontology.org/ontology/RXNORM/"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:j.2="http://purl.bioontology.org/ontology/RXNORM/3407"
    xmlns:j.3="http://purl.bioontology.org/ontology/RXNORM/686438"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8644a3a9-8124-4255-89a3-535580de7366">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f707038f-a71f-4130-9ac9-542dee6264d7"/>
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e934f7f0-d967-4381-b88e-5cfd5545c5dc"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1ccb155e-a910-44d7-b35e-ab70e8a478df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/89b25ecb-02d0-41c8-acd0-9980a40a5cb4">
    <rdf:type rdf:resource="http://purl.bioontology.org/ontology/RXNORM/D014635"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3f07bdca-4434-4509-816f-fd379de9b80d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dabf11e1-9f92-4d53-80f7-2ec3ce3f831f">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1c9eb0ef-eaac-4d77-9104-b59ddaabef0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/67973709-109b-4c13-a41e-2b2d17111100">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f707038f-a71f-4130-9ac9-542dee6264d7"/>
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e934f7f0-d967-4381-b88e-5cfd5545c5dc"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5b7b635b-0899-45c6-8f6c-4f4e7307a915"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/155b419a-fd08-4bf2-acab-8aee32842688">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000022">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000187">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/266d32f9-4fdd-480a-bfd6-48b2d581af91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c25fb416-4562-4c72-8af4-6531ba879368">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ddc0327f-a243-40e1-82e3-6fd334968951"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000221">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/257ab8ef-be23-4ddc-b213-1abfe267ab66">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ad700ae5-c77f-4774-9664-3e0de2015caa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6ec0a984-8a5a-47a6-bad3-6ef2b891bdb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9c02f0fd-e5a3-47a5-b2d6-ee49e0c3a711">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5ebf4c00-920f-4cd3-b232-a2869210d672"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/68680c24-d7ef-4e48-ac09-5a33a7d9448c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/61b6e142-a000-48c0-a0b5-eb9fac0bba1d">
    <rdf:type rdf:resource="http://purl.bioontology.org/ontology/RXNORM/3407"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/11800d3c-8d98-4c16-9ef7-758350989a9b">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d53acebf-b7fa-4717-9d3f-88a614628282"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0bd05683-fd00-43ca-8238-5d77af592186">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f707038f-a71f-4130-9ac9-542dee6264d7"/>
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e934f7f0-d967-4381-b88e-5cfd5545c5dc"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8f219532-5405-403f-b45f-1f6ae53570cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/335b5d77-4cf3-4dff-847a-8140bfd19c1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000050">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f6628319-eb28-4697-9fac-92669a3941c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/68680c24-d7ef-4e48-ac09-5a33a7d9448c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ddc0327f-a243-40e1-82e3-6fd334968951">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fd8a9c0a-e760-49d4-926c-8cf200d0e371">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5b7b635b-0899-45c6-8f6c-4f4e7307a915">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/812d433b-06e2-4180-a91c-34691cd2960b"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1c9eb0ef-eaac-4d77-9104-b59ddaabef0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4a32b684-482b-409b-9aa0-ce4bd3fe13c4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f707038f-a71f-4130-9ac9-542dee6264d7"/>
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e934f7f0-d967-4381-b88e-5cfd5545c5dc"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/382cfac4-2c30-4da1-86a9-38cade235025"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d53acebf-b7fa-4717-9d3f-88a614628282">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6266b22b-da1f-444a-b727-c1e6013d6138">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0bd05683-fd00-43ca-8238-5d77af592186"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8644a3a9-8124-4255-89a3-535580de7366"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9967032f-7d91-4fc0-b7df-25cc9885c93d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c73c703f-2bec-4583-bc6d-2bfd504606d8"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b2fb49a9-31e4-49f3-8723-b5928acedf92">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f6628319-eb28-4697-9fac-92669a3941c0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/dabf11e1-9f92-4d53-80f7-2ec3ce3f831f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a1ce9437-a925-4e8e-9c8b-fec1cf618748">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a6cd0846-2e6d-4dea-ba39-38954aa2f421">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7068e899-fce0-4421-bc66-c781d4d63cf2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c25fb416-4562-4c72-8af4-6531ba879368"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000053">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e934f7f0-d967-4381-b88e-5cfd5545c5dc">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/75360fdf-0595-49a2-85d3-3f1ba2a84679">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5ebf4c00-920f-4cd3-b232-a2869210d672">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9e66c8f3-4554-419d-80f2-eeab7d309b5c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b9636872-61ce-4b72-9235-52578242fe96"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/89b25ecb-02d0-41c8-acd0-9980a40a5cb4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5af8b923-73ae-42cf-bfe2-11e934e1db85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/852fdd39-1e50-4190-9d8e-07f8957184bf">
    <rdf:type rdf:resource="http://purl.bioontology.org/ontology/RXNORM/686438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1469a2a5-1993-4ed5-8cfb-340a275c9074">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4a32b684-482b-409b-9aa0-ce4bd3fe13c4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/67973709-109b-4c13-a41e-2b2d17111100"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/951f6df0-2e07-4c92-badb-9d75d3dd83f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9c02f0fd-e5a3-47a5-b2d6-ee49e0c3a711"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c73c703f-2bec-4583-bc6d-2bfd504606d8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4d29173c-6e18-4e9e-8ca8-c704fec28b06"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a1c32f4b-06a2-4029-8f06-1e3fe8d63482"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9e66c8f3-4554-419d-80f2-eeab7d309b5c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fd8a9c0a-e760-49d4-926c-8cf200d0e371"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/11800d3c-8d98-4c16-9ef7-758350989a9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f707038f-a71f-4130-9ac9-542dee6264d7">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a4cf25e2-c159-4838-a257-734b71b85ae7">
    <rdf:type rdf:resource="http://purl.bioontology.org/ontology/RXNORM/31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4d29173c-6e18-4e9e-8ca8-c704fec28b06">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b2fb49a9-31e4-49f3-8723-b5928acedf92"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3f07bdca-4434-4509-816f-fd379de9b80d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a4cf25e2-c159-4838-a257-734b71b85ae7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7068e899-fce0-4421-bc66-c781d4d63cf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8f219532-5405-403f-b45f-1f6ae53570cc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/75360fdf-0595-49a2-85d3-3f1ba2a84679"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/382cfac4-2c30-4da1-86a9-38cade235025">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/aab80707-9d7b-41ab-938a-7b17881394f8"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/812d433b-06e2-4180-a91c-34691cd2960b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9967032f-7d91-4fc0-b7df-25cc9885c93d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/88084207-f75f-4514-8e78-8032ab472446"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a1ce9437-a925-4e8e-9c8b-fec1cf618748"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1ccb155e-a910-44d7-b35e-ab70e8a478df">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5af8b923-73ae-42cf-bfe2-11e934e1db85"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c8441bb4-b081-4f9c-9599-3615457ea8a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/88084207-f75f-4514-8e78-8032ab472446">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/61b6e142-a000-48c0-a0b5-eb9fac0bba1d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c8441bb4-b081-4f9c-9599-3615457ea8a7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/257ab8ef-be23-4ddc-b213-1abfe267ab66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ad700ae5-c77f-4774-9664-3e0de2015caa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6ec0a984-8a5a-47a6-bad3-6ef2b891bdb7">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/266d32f9-4fdd-480a-bfd6-48b2d581af91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/951f6df0-2e07-4c92-badb-9d75d3dd83f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1709c056-ad27-4a89-8979-46cbc15146ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/335b5d77-4cf3-4dff-847a-8140bfd19c1c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/aab80707-9d7b-41ab-938a-7b17881394f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b9636872-61ce-4b72-9235-52578242fe96">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1709c056-ad27-4a89-8979-46cbc15146ac">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/852fdd39-1e50-4190-9d8e-07f8957184bf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/155b419a-fd08-4bf2-acab-8aee32842688"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a6cd0846-2e6d-4dea-ba39-38954aa2f421"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a1c32f4b-06a2-4029-8f06-1e3fe8d63482">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
</rdf:RDF>
